Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 22,670 | 21,496 | 21,387 | 20,804 | 15,993 |
| Operating Income | -22,670 | -21,496 | -21,387 | -20,804 | -15,993 |
| Other Income | 261 | -137 | 446 | 505 | 550 |
| Pre-tax Income | -22,409 | -21,633 | -20,941 | -20,299 | -15,443 |
| Net Income Continuous | -22,599 | -21,633 | -20,941 | -20,299 | -15,443 |
| Net Income | $-22,599 | $-21,633 | $-20,941 | $-20,299 | $-15,443 |
| EPS Basic Total Ops | -14.20 | -13.40 | -13.00 | -12.80 | 37.20 |
| EPS Basic Continuous Ops | -14.08 | -13.49 | -13.07 | -12.72 | 26.89 |
| EPS Diluted Total Ops | -14.20 | -13.40 | -13.00 | -12.80 | 37.20 |
| EPS Diluted Continuous Ops | -14.08 | -13.49 | -13.07 | -12.72 | 26.89 |
| EBITDA(a) | $-22,170 | $-21,038 | $-21,005 | $-20,544 | $-15,633 |